|Bid||1.9900 x 800|
|Ask||2.0000 x 1200|
|Day's Range||1.8300 - 2.0800|
|52 Week Range||1.1800 - 3.7300|
|Beta (5Y Monthly)||0.63|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 10, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.00|
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that the company will participate in the H.C. Wainwright Global Life Sciences Virtual Conference on March 9-10, 2021, and the Maxim Group and M Vest 2021 Emerging Growth Virtual Conference on March 17-18, 2021.
By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Aethlon Medical, Inc. (NASDAQ:AEMD) reported 3Q FY2021 results last night and provided an updated outlook on the two clinical studies underway. The company is developing products to diagnose and treat diseases in oncology and viral diseases that are life and organ threatening and not addressed with already approved treatments, is setting
NEW YORK, NY / ACCESSWIRE / February 10, 2021 / Aethlon Medical, Inc. (NASDAQ:AEMD) will be discussing their earnings results in their 2021 Third Quarter Earnings call to be held on February 10, 2021 at 4:30 PM Eastern Time.